Foster Victor Wealth Advisors’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,601
Closed -$14.6K 213
2025
Q1
$14.6K Sell
12,601
-5,727
-31% -$7.39K ﹤0.01% 195
2024
Q4
$22.2K Sell
18,328
-3,830
-17% -$4.55K ﹤0.01% 191
2024
Q3
$33.2K Buy
22,158
+1,000
+5% +$1.34K ﹤0.01% 189
2024
Q2
$27.1K Buy
21,158
+185
+0.9% +$251 ﹤0.01% 191
2024
Q1
$21K Buy
20,973
+8,651
+70% +$8.64K ﹤0.01% 172
2023
Q4
$13.3K Buy
+12,322
New +$5.44K ﹤0.01% 170

Other funds holding TLSIW

Foster Victor Wealth Advisors's TLSIW Position: Q2 2025 in Review

Foster Victor Wealth Advisors sold out of TriSalus Life Sciences Warrant (TLSIW) in Q2 2025, closing a stake of 12,601 shares — an estimated $14.6K sold.

Foster Victor Wealth Advisors first reported a position in TLSIW in Q4 2023 and held it in 6 quarters. The position peaked at $33.2K in Q3 2024. 5 funds tracked by Wall St. Rank hold TLSIW as of Q2 2025.

  • Foster Victor Wealth Advisors reported no remaining TriSalus Life Sciences Warrant position as of Q2 2025 after selling out during the quarter.
  • Foster Victor Wealth Advisors sold 12,601 TriSalus Life Sciences Warrant shares in Q2 2025, an estimated $14.6K.
  • Foster Victor Wealth Advisors first reported a position in TriSalus Life Sciences Warrant in Q4 2023 and held it in 6 quarters.
  • Foster Victor Wealth Advisors's TriSalus Life Sciences Warrant position peaked at $33.2K in Q3 2024.
  • 5 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q2 2025.

Based on Foster Victor Wealth Advisors's 13F filing for Q2 2025, filed 15 Jul 2025.